Niagen Bioscience Inc (NAGE)
NASDAQ: NAGE
· Real-Time Price · USD
10.01
0.30 (3.09%)
At close: Aug 15, 2025, 3:59 PM
10.05
0.40%
After-hours: Aug 15, 2025, 07:52 PM EDT
Niagen Bioscience Inc Balance Sheet Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 60.32M | 55.46M | 44.51M | 32.25M | 27.73M | 27.41M | 27.17M | 26.62M | 26.25M | 22.99M | 20.29M | 13.06M | 16.87M | 20.79M | 28.02M | 32.9M | 38.58M | 44.49M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 405K | 458K | 368K | 374K | 394K | 405K | 383K | 454K | 518K | 532K | 497K | 545K | 564K | 606K | 723K | 576K | 617K | 594K |
Receivables | 9.66M | 7.05M | 7.77M | 7.1M | 7.82M | 6.6M | 5.23M | 5.6M | 6.12M | 9.22M | 8.48M | 4.74M | 4.23M | 6.31M | 5.23M | 5.29M | 6M | 4.65M |
Inventory | 14.41M | 11.19M | 9.19M | 10.54M | 11.51M | 12.49M | 14.53M | 12.62M | 11.97M | 11.91M | 14.68M | 15.64M | 15.75M | 15.31M | 13.6M | 12.68M | 12.18M | 12.76M |
Other Current Assets | 2.29M | 2.52M | 1.05M | 2.25M | 2.24M | 2.46M | 2.6M | 2.33M | 2.04M | 2.45M | 3.12M | 200K | 200K | 200K | 200K | 200K | 200K | 200K |
Total Current Assets | 86.68M | 76.22M | 64.1M | 52.13M | 49.3M | 48.98M | 49.53M | 47.18M | 46.38M | 46.56M | 46.57M | 37.9M | 38.51M | 44.52M | 48.91M | 52.84M | 57.93M | 63.22M |
Property-Plant & Equipment | 4.16M | 4.34M | 3.45M | 3.62M | 3.9M | 4.23M | 4.54M | 5.3M | 5.68M | 6.04M | 6.32M | 6.5M | 6.78M | 6.99M | 7.36M | 6.13M | 6.33M | 4.16M |
Goodwill & Intangibles | 284K | 322K | 359K | 397K | 435K | 472K | 510K | 552K | 591K | 630K | 671K | 714K | 758K | 808K | 857K | 908K | 961K | 1.02M |
Total Long-Term Assets | 4.85M | 5.12M | 4.18M | 4.39M | 4.73M | 5.1M | 5.43M | 6.3M | 6.79M | 7.2M | 7.49M | 7.76M | 8.11M | 8.41M | 8.94M | 7.62M | 7.91M | 5.77M |
Total Assets | 91.53M | 81.34M | 68.28M | 56.52M | 54.03M | 54.08M | 54.96M | 53.48M | 53.17M | 53.77M | 54.06M | 45.66M | 46.61M | 52.93M | 57.84M | 60.45M | 65.84M | 68.99M |
Account Payables | 13.68M | 10.63M | 8.53M | 6.9M | 8.11M | 7.9M | 10.23M | 9.2M | 10.03M | 8.95M | 9.68M | 9.12M | 10.2M | 9.78M | 10.42M | 10.8M | 9.97M | 11.69M |
Deferred Revenue | 303K | 207K | 611K | 184K | 156K | 227K | 195K | 189K | 166K | 148K | 157K | 158K | 173K | 141K | 161K | 175K | 210K | 231K |
Short-Term Debt | 963K | 948K | 994K | 1.02M | 985K | 861K | 702K | 864K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | -963K | -948K | -994K | -1.02M | -985K | -861K | -702K | -864K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Current Liabilities | 22.33M | 20.84M | 17.95M | 17.7M | 17.87M | 19.45M | 20.62M | 19.44M | 19.06M | 18.42M | 17.87M | 16.73M | 17.73M | 18.69M | 17.61M | 17.77M | 16.23M | 19.76M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 5M | 5.16M | 4.24M | 4.45M | 5.45M | 5.68M | 5.89M | 6.73M | 6.96M | 7.33M | 7.52M | 7.92M | 8.11M | 8.36M | 8.5M | 7.23M | 7.47M | 5.41M |
Total Liabilities | 27.33M | 25.99M | 22.18M | 22.15M | 23.32M | 25.13M | 26.51M | 26.18M | 26.02M | 25.75M | 25.39M | 24.64M | 25.84M | 27.05M | 26.11M | 25M | 23.7M | 25.16M |
Total Debt | 3.29M | 3.52M | 2.65M | 2.9M | 3.12M | 3.23M | 3.28M | 3.79M | 3.94M | 4.09M | 4.26M | 4.38M | 4.54M | 4.66M | 4.7M | 3.35M | 3.51M | 1.47M |
Common Stock | 79K | 78K | 77K | 76K | 75K | 75K | 75K | 75K | 75K | 74K | 74K | 68K | 68K | 68K | 68K | 68K | 68K | 68K |
Retained Earnings | -173.24M | -176.85M | -181.91M | -189.09M | -190.97M | -190.95M | -190.46M | -190.57M | -189.62M | -187.42M | -185.49M | -184.07M | -183.09M | -176.69M | -168.95M | -163.63M | -154.77M | -149.21M |
Comprehensive Income | -4K | -5K | -4K | -7K | -2K | -1K | -4K | -1K | -1K | n/a | -3K | 3K | 2K | n/a | -2K | -2K | -2K | -2K |
Shareholders Equity | 64.19M | 55.34M | 46.09M | 34.37M | 30.72M | 28.95M | 28.46M | 27.31M | 27.15M | 28.02M | 28.67M | 21.02M | 20.78M | 25.88M | 31.73M | 35.45M | 42.14M | 43.83M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |